Hagemann et al. (2008) showed that inhibition of NF-κB signaling in TAMs switched them into M1 macrophages, which is cytotoxic to tumor cells, and promoted regression of advanced tumors in vivo. This evidence concerns the gene NFKB1 and neoplasm.